ZA85327B - Therapeutic compounds - Google Patents

Therapeutic compounds

Info

Publication number
ZA85327B
ZA85327B ZA85327A ZA85327A ZA85327B ZA 85327 B ZA85327 B ZA 85327B ZA 85327 A ZA85327 A ZA 85327A ZA 85327 A ZA85327 A ZA 85327A ZA 85327 B ZA85327 B ZA 85327B
Authority
ZA
South Africa
Prior art keywords
therapeutic compounds
methyl
phenylpyrazolo
furanyl
ethylamino
Prior art date
Application number
ZA85327A
Other languages
English (en)
Inventor
Sun Hyuk Kim
Jacques-Pierre Moreau
Original Assignee
Biomeasure Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomeasure Inc filed Critical Biomeasure Inc
Publication of ZA85327B publication Critical patent/ZA85327B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA85327A 1984-05-25 1985-01-15 Therapeutic compounds ZA85327B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/614,454 US4565815A (en) 1982-12-30 1984-05-25 Pyrazolo[1,5-a]-1,3,5-triazines

Publications (1)

Publication Number Publication Date
ZA85327B true ZA85327B (en) 1985-12-24

Family

ID=24461318

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA85327A ZA85327B (en) 1984-05-25 1985-01-15 Therapeutic compounds

Country Status (7)

Country Link
US (1) US4565815A (xx)
EP (1) EP0172608B1 (xx)
JP (1) JPS617277A (xx)
AT (1) ATE33655T1 (xx)
CA (1) CA1241957A (xx)
DE (1) DE3562251D1 (xx)
ZA (1) ZA85327B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1267143A (en) * 1985-06-06 1990-03-27 Sun H. Kim Anti-arthritic 7-phenylpyrazole[1,5-a]-1,3,5- triazine derivatives
US4685958A (en) * 1986-05-06 1987-08-11 The Dow Chemical Company Sulfonamides derived from substituted 2-amino-1,2,4-triazolo[1,5-a]-1,3,5-triazines and compositions and methods of controlling undesired vegetation
US4824834A (en) * 1986-10-31 1989-04-25 Otsuka Pharmaceutical Company, Limited Pyrazolotriazine compounds
DE3644343A1 (de) * 1986-12-19 1988-06-30 Schering Ag 6,7-dihydro-(1,2,4)triazolo(1,5-a)(1,3,5) triazin-2-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider und wachstumsregulierender wirkung
GB9111130D0 (en) * 1991-05-23 1991-07-17 Ici Plc Azole derivatives
GB9111131D0 (en) * 1991-05-23 1991-07-17 Ici Plc Heterocyclic compounds
GB9125002D0 (en) * 1991-11-25 1992-01-22 Ici Plc Azole derivatives
US6335339B1 (en) 1998-01-13 2002-01-01 Scriptgen Pharmaceuticals, Inc. Triazine antiviral compounds
US7220328B1 (en) 2001-06-06 2007-05-22 The United States Of America As Represented By The Secretary Of The Navy Low-smoke gas generating low order pressure pulse compositions
US6919453B1 (en) 2001-06-06 2005-07-19 The United States Of America As Represented By The Secretary Of The Navy Colorant compositions
US6423844B1 (en) 2001-06-06 2002-07-23 The United States Of America As Represented By The Secretary Of The Navy Process for making 1,2,4-triazolo[4,3-a][1,3,5]triazine-3,5,7-triamine
US6846926B1 (en) 2001-06-06 2005-01-25 The United States Of America As Represented By The Secretary Of The Navy Triazolyl-aminotriazine compositions, including salts
EP1618109A2 (en) * 2003-04-09 2006-01-25 Biogen Idec MA Inc. Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosine receptor antagonists
WO2004110454A1 (ja) * 2003-06-13 2004-12-23 Ishihara Sangyo Kaisha, Ltd. アデノシンA2a受容体アゴニストの投与が必要な疾患を治療又は予防するための組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
GB2023133B (en) * 1978-04-26 1982-09-08 Glaxo Group Ltd Heterocyclic derivatives
AU2192683A (en) * 1982-12-30 1984-07-05 Biomeasure Incorporated Pyrazolo(1,5-alpha)-1,3,5-triazines

Also Published As

Publication number Publication date
ATE33655T1 (de) 1988-05-15
JPS617277A (ja) 1986-01-13
US4565815A (en) 1986-01-21
DE3562251D1 (xx) 1988-05-26
CA1241957A (en) 1988-09-13
EP0172608B1 (en) 1988-04-20
EP0172608A1 (en) 1986-02-26

Similar Documents

Publication Publication Date Title
ZA85327B (en) Therapeutic compounds
AU4415285A (en) Benzodiazepine derivatives
EP0230949A3 (en) A process for the epoxydation of olefinic compounds
DE3779053D1 (xx)
EP0351865A3 (en) Dc-89 compounds and process for their preparation
SG47986A1 (en) A pharmaceutical solution
AU585539B2 (en) Novel pesticidal N-benzoyl-N'-2,5-dichloro-4- haloalkoxyphenylurea derivatives
GR3004959T3 (xx)
EG19064A (en) Novel heterocyclic pesticidal compounds
JPS6419026A (en) Manufacture of 1,1-disubstituted ethylene compound
AP8800109A0 (en) "Heterocyclic insecticides".
EP0115416A3 (en) Triazole antifungal agents
GR3026105T3 (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
ZA886247B (en) Use of a compound for the treatment of schizophrenia
AU6414286A (en) 1,2,5-substituted imidazole compounds
GB2163161B (en) Herbicidal 2,4-diamino-6-difluoromethylthio-1,3,5 triazine derivatives
EP0178611A3 (en) Process for the preparation of n,n',n''-tris(2-hydroxypropyl) melamine
GB2157683B (en) Fungicidal 2,4-dihalo-5-alkylthio-6-thiocyanopyrimidine compounds
EP0261439A3 (en) Medicament for curing arteriosclerosis, comprising pyrimido (2,1-b) benzothiazole derivative
GR3022217T3 (en) Treatment of cataract with prostacyclin compounds
ZA895086B (en) New 1,4-diazepine derivatives having anti-ulcer activity
GB8530144D0 (en) Imidazo(1,5-a)heterocyclic compounds
DE3369511D1 (en) Heterocyclic compounds, process for their preparation and therapeutic agents containing these compounds
AU580605B2 (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H``-receiptor antagonist activity
HUT49610A (en) New process for producing 5,8,13,14-tetrahydrobenz/5,6/ isoindolo/2,1-b/isoquinolin-8,13-dione derivatives